Register entry
- Registered sites
- 0
- Active NDC listings
- 3
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
33 active NDC listings: 3 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 3.
| Dosage form | NDCs |
|---|---|
| tablet | 3 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| pls analytical | 3 |
Catalogue
Marketed products
3| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Cetirizine Hydrochloride | tablet | 72091-009DRUG FOR FURTHER PROCESSING |
| - | Fexofenadine Hydrochloride | tablet | 72091-010DRUG FOR FURTHER PROCESSING |
| - | Loratadine | tablet | 72091-050DRUG FOR FURTHER PROCESSING |
Compare
Other companies listing cetirizine hydrochloride
- Cardinal Health 418, Inc.34 sites · 833 NDC
- Dr. Reddy's Laboratories Limited15 sites · 683 NDC
- Sun Pharmaceutical Industries Limited13 sites · 918 NDC
- Granules Pharmaceuticals Inc.8 sites · 302 NDC
- Piramal Healthcare (Canada) Limited8 sites · 86 NDC
- Kenvue Brands LLC7 sites · 564 NDC
- CIPLA PHARMACEUTICALS LIMITED7 sites · 368 NDC
- Aurobindo Pharma Limited6 sites · 1,453 NDC
- Sandoz Industrial Products S.A5 sites · 441 NDC
- International Medication Systems, Ltd.3 sites · 2,801 NDC
Enquiry
Common questions
- Is PLS ANALYTICAL FDA approved?
- PLS ANALYTICAL holds no registered establishment of its own; 3 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does PLS ANALYTICAL make?
- 3 products are listed under PLS ANALYTICAL in the openFDA NDC Directory, most often as tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.